| Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen MP Menden, D Wang, MJ Mason, B Szalai, KC Bulusu, Y Guan, T Yu, ... Nature communications 10 (1), 2674, 2019 | 310 | 2019 |
| ProMiR II: a web server for the probabilistic prediction of clustered, nonclustered, conserved and nonconserved microRNAs JW Nam, J Kim, SK Kim, BT Zhang Nucleic acids research 34 (suppl_2), W455-W458, 2006 | 108 | 2006 |
| Grpe: Relative positional encoding for graph transformer W Park, W Chang, D Lee, J Kim, S Hwang ICLR2022 Machine Learning for Drug Discovery, 2022 | 67 | 2022 |
| Industrializing AI/ML during the end-to-end drug discovery process J Yoo, TY Kim, IS Joung, SO Song Current Opinion in Structural Biology 79, 102528, 2023 | 18 | 2023 |
| EpiBERTope: a sequence-based pre-trained BERT model improves linear and structural epitope prediction by learning long-distance protein interactions effectively M Park, S Seo, E Park, J Kim bioRxiv, 2022.02. 27.481241, 2022 | 15 | 2022 |
| MetaDTA: meta-learning-based drug-target binding affinity prediction E Lee, J Yoo, H Lee, S Hong ICLR2022 Machine Learning for Drug Discovery, 2022 | 12 | 2022 |
| Selenium reduction of ubiquinone via SQOR suppresses ferroptosis N Lee, SJ Park, M Lange, T Tseyang, MB Doshi, TY Kim, Y Song, DI Kim, ... Nature Metabolism 6 (2), 343-358, 2024 | 10 | 2024 |
| Artificial intelligence-driven new drug discovery targeting serine/threonine kinase 33 for cancer treatment NL Tran, H Kim, CH Shin, E Ko, SJ Oh Cancer Cell International 23 (1), 321, 2023 | 8 | 2023 |
| Standigm ASK™: knowledge graph and artificial intelligence platform applied to target discovery in idiopathic pulmonary fibrosis S Han, JE Lee, S Kang, M So, H Jin, JH Lee, S Baek, H Jun, TY Kim, ... Briefings in Bioinformatics 25 (2), bbae035, 2024 | 6 | 2024 |
| PWN: enhanced random walk on a warped network for disease target prioritization S Han, J Hong, SJ Yun, HJ Koo, TY Kim BMC bioinformatics 24 (1), 105, 2023 | 5 | 2023 |
| Artificial intelligence-driven drug repositioning uncovers efavirenz as a modulator of α-synuclein propagation: Implications in Parkinson’s disease JB Kim, SJ Kim, M So, DK Kim, HR Noh, BJ Kim, YR Choi, D Kim, H Koo, ... Biomedicine & Pharmacotherapy 174, 116442, 2024 | 4 | 2024 |
| Accelerating Antibody Design with Active Learning S Seo, MW Kwak, E Kang, C Kim, E Park, TH Kang, J Kim BioRxiv, 2022.09. 12.507690, 2022 | 4 | 2022 |
| SCREENER: Streamlined collaborative learning of NER and RE model for discovering gene-disease relations M Park, CU Jeong, YS Baik, DG Lee, JU Park, HJ Koo, TY Kim Plos one 18 (11), e0294713, 2023 | 3 | 2023 |
| Quantum-Informed Molecular Representation Learning Enhancing ADMET Property Prediction ISJ Jungwoo Kim, Woojae Chang, Hyunjun Ji Journal of Chemical Information and Modeling, 2024 | 1 | 2024 |
| Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson’s disease JB Kim, Y Kim, SJ Kim, TY Ha, DK Kim, DW Kim, M So, SH Kim, HG Woo, ... Journal of Neuroinflammation 21 (1), 53, 2024 | 1 | 2024 |
| scCDX: enhancing cancer driver gene identification and model interpretability with single-cell RNA sequencing data and extreme gradient boosting K Lee, J Kim, TY Kim | | 2024 |
| Learning the Relationship Between Variants, Metabolic Fluxes and Phenotypes D Kim, S Han, SH Nam, TY Kim bioRxiv, 2024.03. 04.577140, 2024 | | 2024 |
| Discovery of novel dual A2AA2B adenosine receptor antagonists for cancer immunotherapy HJ Hyo Seon Lee, Siu Kim, Seungchan Kim, Daehyun Cho, Eun Ko Discovery on Target 2022, 2022 | | 2022 |
| Discovery of novel TNIK inhibitor for lung squamous cell carcinoma (LSCC) HJ Eun Ko, Hyoseon Lee, Myeonghwi Lee, Sunyoung Kim, Daehyun Cho, Susung Oh Discovery on Target 2022, 2022 | | 2022 |
| GALAPAGOS: Fragment-based Evolutionary Algorithm for Simultaneous Optimization of Drug-likeness and Affinity IJ Hokyun Jeon, Hui Sun Lee ACS Fall 2022, 2022 | | 2022 |
